CRMD icon

CorMedix
CRMD

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$14
66% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Needham
Needham
Serge Belanger
29% 1-yr CRMD win rate
5 Mar ‘26 2 months ago